Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Through their joint venture Fionet Rapid Response Group, Relay Medical (RELA)  and Fio will provide COVID-19 testing at Canada’s 2022 FIFA World Cup Qatar qualifying matches
  • Athletes will be tested upon arrival in Toronto and then retested in the days leading up to qualifying matches
  • FRR has teamed up with LifeLabs to deliver remote rapid COVID-19 testing and tracking with the Fionet platform
  • The Fionet Platform handles scheduling, on-site check-in, antigen testing and public health notification
  • Relay Medical is a Canadian-based technology innovator
  • Relay Medical Corp. (RELA) opened trading at C$0.225 per share

Relay Medical (RELA) and Fio are partnering to provide COVID-19 testing at Canada’s 2022 FIFA World Cup Qatar qualifying matches.

Their joint venture company, Fionet Rapid Response Group (FRR)  will provide rapid COVID-19 testing and real-time tracking.

Canada will play Honduras on September 2 and El Salvador on September 8 at BMO Field in Toronto as part of the Concacaf Final Round qualifying games for the 2022 FIFA World Cup™ in Qatar.

Athletes will be tested for COVID-19 upon arrival in Toronto and then retested in the days leading up to qualifying matches. The testing will take place near BMO field.

Yoav Raiter, CEO Relay Medical Corp. remarked,

“Soccer is a powerful international sport that sees fans and participants from all over the world. FRR is proud to test at the prestigious FIFA qualifying events hosted here at home in Toronto. We wish everyone involved exciting, competitive and safe matches next week.”

FRR has teamed up with LifeLabs to deliver remote rapid COVID-19 testing and tracking with the Fionet platform. The Fionet platform has been integrated into LifeLabs’ laboratory information system and COVID-19 rapid diagnostic testing (RDT) program to support Canadians as they return to work.

FRR’s Fionet provides fast, scalable, quality-controlled testing and real-time digital results for electronic reporting in community-based or decentralized settings. It has been integrated into LifeLabs’ laboratory information system as a turnkey, end-to-end COVID-19 rapid diagnostic testing (RDT) program for testing and real-time tracking of COVID-19 at BMO Field in Toronto.

The Fionet Platform is a rapid testing and tracking solution for community-based settings. The platform can do scheduling and registration through the phone app at home, on-site check-in, on-the-spot antigen testing, data integration with other testing devices and provide result notifications.

Relay Medical is a Canadian-based technology innovator focused on the development of novel technologies in the diagnostics and AI data science sectors.

Relay Medical Corp. (RELA) opened trading at C$0.225 per share.

More From The Market Herald
Mountain Boy Minerals - CEO, Lawrence Roulston (right).

" Mountain Boy Minerals (TSXV:MTB) samples high-grade silver in B.C.

Mountain Boy Minerals (MTB) has announced further high-grade silver results on its Theia Project in B.C.
Levitee Labs - CEO, Pouya Farmand.

" Levitee Labs (CSE:LVT) partners with Adracare for addiction and mental health support

Levitee Labs (LVT) has signed an agreement with Adracare to develop a platform for mental health services.

" Equity Metals (TSXV:EQTY) announces private placement

Equity Metals (EQTY) has announced a non-brokered private placement for gross proceeds of up to $6,000,000.
HEXO Corp - Departing CEO, Sebastien St. Louis.

" HEXO’s (TSX:HEXO) St-Louis out as CEO

HEXO (HEXO) has announced executive changes as it completes a strategic reorganization.